e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
New modalities and application in lung and airway imaging
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of acute smoking on pulmonary inflammatory cell activity measured by positron emission tomography (PET) in asymptomatic cigarette smokers
H. A. Jones, H. M. Branley, R. J. Shiner, A. R. Boobis (London, United Kingdom)
Source:
Annual Congress 2005 - New modalities and application in lung and airway imaging
Session:
New modalities and application in lung and airway imaging
Session type:
Oral Presentation
Number:
3030
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. A. Jones, H. M. Branley, R. J. Shiner, A. R. Boobis (London, United Kingdom). Influence of acute smoking on pulmonary inflammatory cell activity measured by positron emission tomography (PET) in asymptomatic cigarette smokers. Eur Respir J 2005; 26: Suppl. 49, 3030
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Imaging the inflammatory activity of sarcoidosis
Source: Eur Respir J 2013; 41: 743-751
Year: 2013
Measurement of airway inflammation in smokers by means of positron emission tomography
Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation
Year: 2012
In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma
Source: Eur Respir J 2003; 21: 567-573
Year: 2003
The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004
Quantitative
18
F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD
Source: ERJ Open Res, 7 (3) 00699-2020; 10.1183/23120541.00699-2020
Year: 2021
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001
Rebuttal
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005
(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008
Advances in chest imagery
Source: Annual Congress 2006 - Clinical year in review
Year: 2006
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009
Positron emission tomography (PET) using
18
F-fluorodeoxyglucose (
18
FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways
Source: Eur Respir J 2001; 18: Suppl. 33, 18s
Year: 2001
The place of non-invasive techniques (CT - PET - CT)
Source: Annual Congress 2007 - Mediastinal staging for NSCLC
Year: 2007
New imaging techniques in the treatment guidelines for lung cancer
Source: Eur Respir J 2002; 19: 71S-83S
Year: 2002
Single photon emission computed tomography (SPECT) in the non-invasive diagnosis cardiac sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 356s
Year: 2006
18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Imaging in lung cancer: positron emission tomography scan
Source: Eur Respir J 2002; 19: 49S-60S
Year: 2002
Single photon emission tomography combined with computer tomography (SPECT/CT) for assessment of COPD patients for lung volume reduction surgery
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008
Imaging can replace mediastinoscopy: PRO
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005
Assessing nodules detected in lung cancer screening: the value of positron emission tomography
Source: Eur Respir J 2015; 45: 314-316
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept